Uncovering the hidden genetic connections behind COVID-19 and comorbidities

FHS
June 21, 2023
9:19 am

Researchers performed a protein diffusion network analysis using tissue-specific GRNs to identify predispositions to COVID-19.

Fibroblastic reticular cells power immune defenses in lung cancer

Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, clustering, and activation. This study highlights FRCs’ potential as therapeutic targets

December 2, 2024

New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by

April 28, 2024

New research highlights regional variations in COPD prevalence according to diagnostic criteria

The global and regional prevalence of Chronic Obstructive Pulmonary Disease (COPD).

January 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.